T1	eligibility 411 456	Patients with clinical stage I and II disease
T2	outcome-Measure 735 769	time to first locoregional relapse
T3	total-participants 871 874	707
T5	age 930 938	59 years
T4	intervention 64 101	optimal fractionation of radiotherapy
T6	outcome 1036 1044	relapsed
T7	iv-bin-abs 1046 1049	110
T8	cv-bin-abs 1064 1067	161
T9	outcome 1089 1127	site of first relapse was locoregional
T10	outcome 1141 1148	distant
T11	outcome 1203 1272	risk of any competing event (local relapse, distant relapse or death)
T13	outcome 1516 1544	risk of locoregional relapse
T12	control 537 552	no radiotherapy
T14	iv-bin-percent 1548 1551	62%
T15	iv-bin-percent 1182 1185	24%
